Arch Venture Partners Ix, LLC is > 10% Shareholder of Beam Therapeutics Inc.. Currently has a direct ownership of 28,111 shares of BEAM, which is worth approximately $803,412. The most recent transaction as insider was on Jun 30, 2021, when has been sold 8,052 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
0% 12M change
Total Value Held $803,412

ARCH Venture Partners IX, LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Other acquisition or disposition
-
8,052 Added 22.27%
28,111 Common Stock
Jun 29 2021
BUY
Other acquisition or disposition
-
8,052 Added 25.58%
23,425 Common Stock
Jun 25 2021
BUY
Other acquisition or disposition
-
8,052 Added 30.05%
18,739 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
-
3,366 Added 58.03%
2,434 Common Stock
Mar 22 2021
BUY
Other acquisition or disposition
-
3,368 Added 67.48%
1,623 Common Stock
Mar 18 2021
BUY
Other acquisition or disposition
-
3,363 Added 80.59%
810 Common Stock

Also insider at

KRTX
Karuna Therapeutics, Inc. Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
LYEL
Lyell Immunopharma, Inc. Healthcare
AVP

Arch Venture Partners Ix, LLC

> 10% Shareholder
Chicago, IL

Track Institutional and Insider Activities on BEAM

Follow Beam Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM